GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD...
NImmune Biopharma and BioTherapeutics have partnered to develop new precision me...
German life science company Evotec has announced a collaboration with X-Chem to ...
The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology pr...
Biogen plans to apply for regulatory approval of this investigational dose regim...
The company had focused its resources on Filspari’s launch in IgAN after the US ...
Onward Medical revealed that it has received a major grant from the Christopher ...
In a decision expected to limit Brussels’ merger authority, American gene sequen...
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of th...
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The tr...
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-hom...
The UK government has taken a step towards banning xylazine and 21 other substan...
ArsenalBio has secured $325m in a Series C financing round to propel its program...
Eli Lilly and EVA Pharma have formed a partnership to increase the availability ...
